LAURUSLABS

Laurus Labs Ltd., incorporated in 2005, is a research-focused pharmaceutical and biotechnology company operating in the pharmaceuticals, biotechnology, human and animal health, crop science, and specialty ingredients industries. The company specializes in manufacturing Active Pharmaceutical Ingredients (APIs), including those for anti-retroviral, oncology (with high-potency APIs), cardiovascular, and gastro therapeutics. It also offers integrated Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) services ranging from clinical phase drug development to commercial production. Laurus Labs holds a global leadership position in select APIs and serves as a preferred partner for both innovator and generic pharmaceutical firms. It operates more than 11 manufacturing facilities approved by regulatory agencies such as USFDA, WHO-Geneva, Japan-PDMA, UK-MHRA, EMA, and TGA. The company employs over 6,500 individuals, including approximately 1,050 scientists.